公司名称: |
南京圣赛化工有限公司 |
联系电话: |
13951876367 |
产品介绍: |
中文名称:依曲韦林 英文名称:Etravirine CAS:269055-15-4 纯度:97% 包装信息:5G 10G 25G 100G 备注:现货 |
公司名称: |
上海波以尔化工有限公司 |
联系电话: |
Mr Qiu 86-21-50182298(Domestic Market)Miss Xu 86-21-50180596(Abroad Market) |
产品介绍: |
中文名称:4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈 英文名称:4-6-amino-5-bromo-2-(4-cyanophenyl)amino-4-pyrimidinyloxy-3, 5 –dimethylbenzonitrile CAS:269055-15-4
|
公司名称: |
百灵威科技有限公司 |
联系电话: |
400-666-7788 +86-10-82848833 |
产品介绍: |
中文名称:4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈 英文名称:Etravirine CAS:269055-15-4 包装信息:50Mg,5Mg 备注:化学试剂、精细化学品、医药中间体、材料中间体 |
公司名称: |
南京药石药物研发有限公司 |
联系电话: |
400 025 5188 |
产品介绍: |
英文名称:benzonitrile, 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl- CAS:269055-15-4 纯度:97% HPLC 包装信息:1GR;10GR;50GR;100GR;250GR;500GR;1KG;5KG;10KG |
公司名称: |
上海佰世凯化学科技有限公司 |
联系电话: |
+86(0)21-20908456 |
产品介绍: |
英文名称:Etravirine CAS:269055-15-4 备注:C13653 |
|
中文名称: | Etravirine (TMC125) | 中文同义词: | 4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈;依曲韦林;依曲韦林 | 英文名称: | Etravirine (TMC125) | 英文同义词: | 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3, 5 –dimethylbenzonitrile;Etravirine;Etravirine(TMC-125);R 165335;TMC 125;4-(6-amino-5-bromo-2-(4-cyanobenzyl)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile, Etravirine;4-[[6-AMino-5-broMo-2-[(4-cyanophenyl)aMino]-4-pyriMidinyl]oxy]-3,5-diMethyl
-;4-[[6-aMino-5-broMo-2-[(4-cyanophenyl)aMino]-4-pyriMidinyl]oxy]-3, 5 –diMethylbenzonitrile/Etravirine | CAS号: | 269055-15-4 | 分子式: | C20H15BrN6O | 分子量: | 435.284 | EINECS号: | | 相关类别: | All Inhibitors;Inhibitors;Intermediates & Fine Chemicals;Non-nucleoside Reverse Transcriptase;Pharmaceuticals;新型抗HIV药;原料药;信号转导通路激酶抑制剂;杂环类;原料药中间体;Other APIs |
熔点 | .265°C (dec.) | 储存条件 | -20°C Freezer |
生物活性 | Etravirine (TMC125)是一种非核苷类逆转录酶抑制剂(NNRTI),用于治疗HIV。 | 体外研究 | Etravirine (TMC125), is highly active against wild-type HIV-1 with EC50 of 1.4 nM to 4.8 nM and shows some activity against HIV-2 with EC50 of 3.5 μM. TMC125 also inhibits a series of HIV-1 group M subtypes and circulating recombinant forms and a group O virus. | 体内研究 | Etravirine has a high genetic barrier to the development of resistance. In phase IIb trials in treatment-experienced patients, including those infected with virus resistant to NNRTIs and protease inhibitors (PIs), TMC125 is active against HIV resistant to currently available NNRTIs, with a similar tolerability profile to that of the control group. |
|